Propranolol in acute myocardial infarction in man: effects of haemodynamics and myocardial oxygenation
- PMID: 967769
Propranolol in acute myocardial infarction in man: effects of haemodynamics and myocardial oxygenation
Abstract
Improvement of myocardial oxygenation is a major goal in the treatment of ischaemic heart disease. Propranolol, 0-1 mg/kg intravenously, was administered to 20 patients with acute myocardial infarction without clinical evidence of left ventricular failure. The most important haemodynamic response was a substantial decrease in myocardial contractility. This was reflected by a fall in cardiac index (average of 0-4 l/min/M2, P less than 0-001) and of arterial mean pressure (average of 16 mmHg, P less than 0-001) with little change in systemic vascular resistance. Heart rate, not strikingly increased at the control state in the majority of patients, decreased an average of 7 beats/minute (P less than 0-001). Pulmonary wedge pressure varied; it decreased in 6 patients with high values (greater than 15 mmHg) prior to propranolol. These changes in wedge pressure in the presence of decreased contractility are probably related to improved left ventricular compliance, produced by propranolol. Propranolol markedly improved myocardial metabolism. Arterial-coronary sinus oxygen difference decreased an average of 0-72 ml/100 ml (P less than 0-001). Myocardial lactate production shifted to extraction (average of -8% to 14%) or the rate of lactate extraction increased (average of 20% to 29%). Coronary blood flow decreased an average of 13 ml/100 g/min (P less than 0-001). The finding, that myocardial metabolism improved, suggests that decrease in coronary blood flow was mediated by reduced myocardial oxygen requirements. None of the 20 patients developed left ventricular failure or other complications related to beta-adrenergic blockade. Severe chest pain, unresponsive to conventional therapy in four patients, was relieved by propranolol. These findings demonstrate that acutely administered propranolol improves myocardila oxygenation in patients with uncomplicated acute infarction without endangering perfusion of other vital organs.
Similar articles
-
[Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].Herz. 1995 Dec;20(6):399-411. Herz. 1995. PMID: 8582699 German.
-
Metabolic control of the circulation. Effects of acetate and pyruvate.J Clin Invest. 1978 Nov;62(5):1029-38. doi: 10.1172/JCI109207. J Clin Invest. 1978. PMID: 568632 Free PMC article.
-
[Acute hemodynamic and coronary effects of captopril in chronic cardiac failure].Arch Mal Coeur Vaiss. 1984 Aug;77(8):865-71. Arch Mal Coeur Vaiss. 1984. PMID: 6435565 French.
-
Propranolol and experimental myocardial infarction: substrate effects.Postgrad Med J. 1976;52 Suppl 4:124-32. Postgrad Med J. 1976. PMID: 787952 Review.
-
Use of catecholamines in acute myocardial infarction.Herz. 1979 Oct;4(5):385-96. Herz. 1979. PMID: 391685 Review.
Cited by
-
Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction.Eur J Clin Pharmacol. 1986;29(6):659-65. doi: 10.1007/BF00615955. Eur J Clin Pharmacol. 1986. PMID: 2872054 Clinical Trial.
-
Pharmacokinetic and haemodynamic studies with labetalol in acute myocardial infarction.Ir J Med Sci. 1983 May;152(5):179-86. doi: 10.1007/BF02954714. Ir J Med Sci. 1983. PMID: 6874287 No abstract available.
-
Is the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds relevant in acute myocardial infarction?Eur J Clin Pharmacol. 1984;27(5):509-15. doi: 10.1007/BF00556884. Eur J Clin Pharmacol. 1984. PMID: 6151504 Clinical Trial.